X
XBIT
Xbiotech
2.340
+0.050+2.18%After Hours: 2.368 +0.028 +1.21%18:25 04/08 EDT
OPEN/PREV CLOSE2.360/2.290
TODAY RANGE2.320-2.390
VOL29.24K
MARKET CAP71.34M
52 WEEK RANGE2.090-3.620
AVG VOL (3M)39.75K
% TURNOVER0.10%
TURNOVER--
P/E (TTM)-1.5666
% RANGE3.05%
EPS(TTM)-1.4937
P/E(FORWARD)-1.3526
P/B0.5083
BVPS4.604
DIVIDEND--
P/S669.70
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP45.22M
SHARES OUTSTANDING30.49M
NEXT EARNINGS05/12-05/18
FREE FLOAT19.32M
LOT SIZE1
EX-DATE07/15/2021
News
Press Releases
Financial Reports
Profile
TipRanks·12/09/2025 14:29
XBiotech CEO John Simard Announces Retirement
Reuters·12/09/2025 14:04
XBIOTECH INC - SUSHMA SHIVASWAMY APPOINTED INTERIM CEO OF XBIOTECH - SEC FILING
Reuters·12/09/2025 14:01
XBiotech Raises Interim CEO Sushma Shivaswamy’s Salary to $750,000
Benzinga·11/12/2025 22:24
XBiotech Q3 EPS $(0.20) Down From $(0.16) YoY
Simply Wall St·11/04/2025 10:10
We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely
TipRanks·10/27/2025 17:52
XBiotech’s New Trial: A Potential Game-Changer for Rheumatoid Arthritis Treatment?
TipRanks·10/03/2025 15:48
XBiotech Signs New Executive Agreement with CEO
Reuters·09/30/2025 14:20
XBiotech Inc. Files Initial Statement of Beneficial Ownership for Director David Spencer Soffer
Reuters·09/30/2025 13:22
XBiotech Inc. Files Initial Statement of Beneficial Ownership for Director Thomas Kuendig
Same Industry
Name/Symbol
Change%
Price